High prevalence of asymptomatic bacterial colonization of rhythm management devices

Europace

Volumn 10, Issue 9, 2008, Pages 1067-1072

  Pichlmaier, Maximilian ^a   Marwitz, Verena ^a   Kühn, Christian ^a   Niehaus, Michael ^a   Klein, Gunnar ^a   Bara, Christof ^a   Haverich, Axel ^a   Abraham, Wolf Rainer ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Defibrillators; Device changes; Infection; Pacemakers; Rhythm management devices; Risk factors

Indexed keywords

BACTERIAL DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL STRAIN; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE INFECTION; DISEASE CARRIER; DNA DETERMINATION; DNA SEQUENCE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INFECTION RISK; MALE; NONHUMAN; PACEMAKER; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE STRAND CONFORMATION POLYMORPHISM; STAPHYLOCOCCUS; ARTIFICIAL HEART PACEMAKER; GERMANY; INFECTION; MICROBIOLOGY; MIDDLE AGED; MYOCARDITIS; RISK FACTOR; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; MYOCARDITIS; PACEMAKER, ARTIFICIAL; PREVALENCE; PROSTHESIS-RELATED INFECTIONS; RISK ASSESSMENT; RISK FACTORS;

EID: 55249118937     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun191     Document Type: Article

References (42)

1. Maisel WH. Cardiovascular device development: lessons learned from pacemaker and implantable cardioverter-defibrillator therapy. Am J Ther 2005;12:183-5.
2. Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA 2006;295:809-18.
3. Cabell CH, Heidenreich PA, Chu VH, Moore CM, Stryjewski ME, Corey GR et al. Increasing rates of cardiac device infections among medicare beneficiaries: 1990-1999. Am Heart J 2004;147:582-6.
4. Uslan DZ, Sohail MR, St Sauver JL, Friedman PA, Hayes DL, Stoner SM et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 2007;167:669- 75.
5. Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol 2006;48:590-1.
6. Chambers ST. Diagnosis and management of staphylococcal infections of pacemakers and cardiac defibrillators. Intern Med J 2005;35:S63- 71.
7. tdel Rio A, Anguera I, Miro JM, Mont L, Fowler VG Jr, Azqueta M et al. Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. Chest 2003;124:1451-9.
8. Hemmer W, Frohlig G, Markewitz A. Comment on NASPE recommendations for removal of permanently implanted, transvenous cardiac pacemaker and defibrillator electrodes. Z Kardiol 2002;91:956-68.
9. Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JL et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 1997;95:2098- 107.
10. Lo R, D'Anca M, Cohen T, Kerwin T. Incidence and prognosis of pacemaker lead-associated masses: a study of 1569 transesophageal echocardiograms. J Invasive Cardiol 2006;18:599-601.
11. Love CJ, Wilkoff BL, Byrd CL, Belott PH, Brinker JA, Fearnot NE et al. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: indications, facilities, training. North American Society of Pacing and Electrophysiology Lead Extraction Conference Faculty. Pacing Clin Electrophysiol 2000;23:544-51.
12. Sohail MR. Management of infected pacemakers and implantable cardioverter-defibrillators. Intern Med J 2007;37:509-10.
13. Uslan DZ, Baddour LM. Cardiac device infections: getting to the heart of the matter. Curr Opin Infect Dis 2006;19:345-8.
14. Bloom H, Heeke B, Leon A, Mera F, Delurgio D, Beshai J et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006;29:142-5.
15. Dasgupta A, Montalvo J, Medendorp S, Lloyd-Jones DM, Ghossein C, Goldberger J et al. Increased complication rates of cardiac rhythm management devices in ESRD patients. Am J Kidney Dis 2007;49:656- 63.
16. Borer A, Gilad J, Hyam E, Schlaeffer F, Schlaeffer P, Eskira S et al. Prevention of infections associated with permanent cardiac antiarrhythmic devices by implementation of a comprehensive infection control program. Infect Control Hosp Epidemiol 2004;25:492-7.
17. Catanchin A, Murdock CJ, Athan E. Pacemaker infections: a 10-year experience. Heart Lung Circ 2007.
18. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 2007;45:166-73.
19. Uslan DZ, Sohail MR, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM et al. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis 2006;43:731-6.
20. Massoure PL, Reuter S, Lafitte S, Laborderie J, Bordachard P, Clementy J et al. Pacemaker endocarditis: clinical features and management of 60 consecutive cases. Pacing Clin Electrophysiol 2007;30:12-9.
21. Da CA, Lelievre H, Kirkorian G, Celard M, Chevalier P, Vandenesch F et al. Role of the preaxillary flora in pacemaker infections: a prospective study. Circulation 1998;97:1791-5.
22. Klug D, Wallet F, Kacet S, Courcol RJ. Involvement of adherence and adhesion Staphylococcus epidermidis genes in pacemaker lead-associated infections. J Clin Microbiol 2003;41:3348-50.
23. Klug D, Wallet F, Lacroix D, Marquie C, Kouakam C, Kacet S et al. Local symptoms at the site of pacemaker implantation indicate latent systemic infection. Heart 2004;90:882-6.
24. Dy CJ, bdul-Karim A, Mawhorter S, Procop GW, Tchou P, Niebauer M et al. The role of swab and tissue culture in the diagnosis of implantable cardiac device infection. Pacing Clin Electrophysiol 2005;28:1276- 81.
25. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007;49:1851-9.
26. Da CA, Kirkorian G, Cucherat M, Delahaye F, Chevalier P, Cerisier A et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 1998;97:1796-801.
27. Dwivedi SK, Saran RK, Khera P, Tripathi N, Kochar AK, Narain VS et al. Short-term (48 hours) versus long-term (7 days) antibiotic prophylaxis for permanent pacemaker implantation. Indian Heart J 2001;53:740- 2.
28. Blaser MJ, Kirschner D. The equilibria that allow bacterial persistence in human hosts. Nature 2007;449:843-9.
29. Schwieger F, Tebbe CC. A new approach to utilize PCR-single-strand- conformation polymorphism for 16S rRNA gene-based microbial community analysis. Appl Environ Microbiol 1998;64:4870-6.
30. Bassam BJ, Caetano-Anolles G, Gresshoff PM. Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem 1991;196:80- 3.
31. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997;25:4876- 82.
32. Kanz C, Aldebert P, Althorpe N, Baker W, Baldwin A, Bates K et al. The EMBL nucleotide sequence database. Nucleic Acids Res 2005;33:D29-33.
33. Kumar S, Tamura K, Nei M. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 2004;5:150-63.
34. Mela T, McGovern BA, Garan H, Vlahakes GJ, Torchiana DF, Ruskin J et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants. Am J Cardiol 2001;88:750-3.
35. Cosio FG, Hebert LA, Birmingham DJ, Dorval BL, Bakaletz AP, Kujala GA et al. Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the nonhuman primate. Clin Immunol Immunopathol 1987;42:1-9.
36. Emlen W, Mannik M. Clearance of circulating DNA-anti-DNA immune complexes in mice. J Exp Med 1982;155:1210-5.
37. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999;64:218-24.
38. Tak T, Reed KD, Haselby RC, McCauley CS Jr, Shukla SK. An update on the epidemiology, pathogenesis and management of infective endocarditis with emphasis on Staphylococcus aureus. WMJ 2002;101:24-33.
39. Behrendt U, Ulrich A, Schumann P. Fluorescent pseudomonads associated with the phyllosphere of grasses; Pseudomonas trivialis sp. nov., Pseudomonas poae sp. nov. and Pseudomonas congelans sp. nov. Int J Syst Evol Microbiol 2003;53:1461-9.
40. Lai CC, Teng LJ, Hsueh PR, Yuan A, Tsai KC, Tang JL et al. Clinical and microbiological characteristics of Rhizobium radiobacter infections. Clin Infect Dis 2004;38:149-53.
41. Miragliotta G, Mosca A, Tantimonaco G, De NR, Antonetti R, Di TA. Relapsing brucellosis related to pacemaker infection. Ital Heart J 2005;6:612-3.
42. Seifert H, Wisplinghoff H, Schnabel P, von EC. Small colony variants of Staphylococcus aureus and pacemaker-related infection. Emerg Infect Dis 2003;9:1316-8.